-
1
-
-
0037097595
-
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: Therapeutic implications
-
Mitsiades N, Mitsiades CS, Poulaki V, et al: Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: Therapeutic implications. Blood 99:4525-4530, 2002
-
(2002)
Blood
, vol.99
, pp. 4525-4530
-
-
Mitsiades, N.1
Mitsiades, C.S.2
Poulaki, V.3
-
2
-
-
0034331194
-
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
-
Hideshima T, Chauhan D, Shima Y, et al: Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood 96:2943-2950, 2000
-
(2000)
Blood
, vol.96
, pp. 2943-2950
-
-
Hideshima, T.1
Chauhan, D.2
Shima, Y.3
-
3
-
-
0033168605
-
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha
-
Corral LG, Haslett PA, Muller GW, et al: Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol 163:380-386, 1999
-
(1999)
J Immunol
, vol.163
, pp. 380-386
-
-
Corral, L.G.1
Haslett, P.A.2
Muller, G.W.3
-
4
-
-
0029925419
-
Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade
-
Geitz H, Handt S, Zwingenberger K: Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade. Immunopharmacology 31:213-221, 1996
-
(1996)
Immunopharmacology
, vol.31
, pp. 213-221
-
-
Geitz, H.1
Handt, S.2
Zwingenberger, K.3
-
5
-
-
0032100486
-
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset
-
Haslett PA, Corral LG, Albert M, et al: Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. J Exp Med 187:1885-1892, 1998
-
(1998)
J Exp Med
, vol.187
, pp. 1885-1892
-
-
Haslett, P.A.1
Corral, L.G.2
Albert, M.3
-
6
-
-
0035412366
-
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
-
Davies FE, Raje N, Hideshirna T, et al: Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood 98:210-216, 2001
-
(2001)
Blood
, vol.98
, pp. 210-216
-
-
Davies, F.E.1
Raje, N.2
Hideshirna, T.3
-
7
-
-
0035186865
-
Thalidomide and its analogues inhibit lipopolysaccharide-mediated induction of cyclooxygenase-2
-
Fujita J, Mestre JR, Zeldis JB, et al: Thalidomide and its analogues inhibit lipopolysaccharide-mediated induction of cyclooxygenase-2. Clin Cancer Res 7:3349-3355, 2001
-
(2001)
Clin Cancer Res
, vol.7
, pp. 3349-3355
-
-
Fujita, J.1
Mestre, J.R.2
Zeldis, J.B.3
-
9
-
-
0031171663
-
Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization
-
Kenyon BM, Browne F, D'Amato RJ: Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res 64:971-978, 1997
-
(1997)
Exp Eye Res
, vol.64
, pp. 971-978
-
-
Kenyon, B.M.1
Browne, F.2
D'Amato, R.J.3
-
10
-
-
0036579909
-
Effects of putative hydroxylated thalidomide metabolites on blood vessel density in the chorioallantoic membrane (CAM) assay and on tumor and endothelial cell proliferation
-
Marks MG, Shi J, Fry MO, et al: Effects of putative hydroxylated thalidomide metabolites on blood vessel density in the chorioallantoic membrane (CAM) assay and on tumor and endothelial cell proliferation. Biol Pharm Bull 25: 597-604, 2002
-
(2002)
Biol Pharm Bull
, vol.25
, pp. 597-604
-
-
Marks, M.G.1
Shi, J.2
Fry, M.O.3
-
11
-
-
0037262242
-
Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis n vivo
-
Lentzsch S, LeBlanc R, Podar K, et al: Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis n vivo. Leukemia 17:41-44, 2003
-
(2003)
Leukemia
, vol.17
, pp. 41-44
-
-
Lentzsch, S.1
LeBlanc, R.2
Podar, K.3
-
12
-
-
0041805647
-
Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells
-
Li X, Liu X, Wang J, et al: Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells. Anticancer Res 23:2481-2487, 2003
-
(2003)
Anticancer Res
, vol.23
, pp. 2481-2487
-
-
Li, X.1
Liu, X.2
Wang, J.3
-
13
-
-
0032748385
-
Antitumor activity of thalidomide in refractory multiple myeloma
-
Singhal S, Mehta J, Desikan R, et al: Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341:1565-1571, 1999
-
(1999)
N Engl J Med
, vol.341
, pp. 1565-1571
-
-
Singhal, S.1
Mehta, J.2
Desikan, R.3
-
14
-
-
1542608411
-
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma
-
Kumar S, Witzig TE, Dispenzieri A, et al: Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma. Leukemia 18:624-627, 2004
-
(2004)
Leukemia
, vol.18
, pp. 624-627
-
-
Kumar, S.1
Witzig, T.E.2
Dispenzieri, A.3
-
15
-
-
0033835945
-
Angiogenic factors in multiple myeloma: Higher levels in bone marrow than in peripheral blood
-
Di Raimondo F, Azzaro MP, Palumbo G, et al: Angiogenic factors in multiple myeloma: Higher levels in bone marrow than in peripheral blood. Haematologica 85:800-805, 2000
-
(2000)
Haematologica
, vol.85
, pp. 800-805
-
-
Di Raimondo, F.1
Azzaro, M.P.2
Palumbo, G.3
-
16
-
-
2642520461
-
Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment
-
Du W, Hattori Y, Hashiguchi A, et al: Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment. Pathol Int 54:285-294, 2004
-
(2004)
Pathol Int
, vol.54
, pp. 285-294
-
-
Du, W.1
Hattori, Y.2
Hashiguchi, A.3
-
17
-
-
0142183449
-
Endothelial cells in the bone marrow of patients with multiple myeloma
-
Vacca A, Ria R, Semeraro F, et al: Endothelial cells in the bone marrow of patients with multiple myeloma. Blood 102:3340-3348, 2003
-
(2003)
Blood
, vol.102
, pp. 3340-3348
-
-
Vacca, A.1
Ria, R.2
Semeraro, F.3
-
18
-
-
0034924216
-
Angiogenesis research: Guidelines for translation to clinical application
-
Folkman J, Browder T, Palmblad J: Angiogenesis research: Guidelines for translation to clinical application. Thromb Haemost 86:23-33, 2001
-
(2001)
Thromb Haemost
, vol.86
, pp. 23-33
-
-
Folkman, J.1
Browder, T.2
Palmblad, J.3
-
19
-
-
0036797073
-
Impact of insulin-like growth factor receptor-1 function on angiogenesis, growth, and metastasis of colon cancer
-
Reinmuth N, Fan F, Liu W, et al: Impact of insulin-like growth factor receptor-1 function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 82:1377-1389, 2002
-
(2002)
Lab Invest
, vol.82
, pp. 1377-1389
-
-
Reinmuth, N.1
Fan, F.2
Liu, W.3
-
20
-
-
0344655675
-
Insulin-like growth factor binding proteins: New proteins, new functions
-
Ferry RJ, Jr., Cerri RW, Cohen P: Insulin-like growth factor binding proteins: new proteins, new functions. Norm Res 51:53-67, 1999
-
(1999)
Norm Res
, vol.51
, pp. 53-67
-
-
Ferry Jr., R.J.1
Cerri, R.W.2
Cohen, P.3
-
21
-
-
2942711726
-
Thalidomide: Current role in the treatment of non-plasma cell malignancies
-
Kumar S, Witzig TE, Rajkumar SV: Thalidomide: Current role in the treatment of non-plasma cell malignancies. J Clin Oncol 22: 2477-2488, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 2477-2488
-
-
Kumar, S.1
Witzig, T.E.2
Rajkumar, S.V.3
-
22
-
-
0034872059
-
Management of Kaposi sarcoma: The role of Interferon and thalidomide
-
Krown SE: Management of Kaposi sarcoma: The role of Interferon and thalidomide. Curr Opin Oncol 13:374-381, 2001
-
(2001)
Curr Opin Oncol
, vol.13
, pp. 374-381
-
-
Krown, S.E.1
-
23
-
-
0038509089
-
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group
-
International Myeloma Working Group
-
International Myeloma Working Group: Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group. Br J Haematol 121:749-757, 2003
-
(2003)
Br J Haematol
, vol.121
, pp. 749-757
-
-
-
24
-
-
0022973287
-
Staging and kinetics of multiple myeloma
-
Durie BG: Staging and kinetics of multiple myeloma. Semin Oncol 13:300-309, 1986
-
(1986)
Semin Oncol
, vol.13
, pp. 300-309
-
-
Durie, B.G.1
-
25
-
-
8244221004
-
The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line
-
Albini A, Paglieri I, Orengo G, et al: The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 11:713-721, 1997
-
(1997)
AIDS
, vol.11
, pp. 713-721
-
-
Albini, A.1
Paglieri, I.2
Orengo, G.3
-
26
-
-
0032100604
-
Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent
-
Bauer KS, Dixon SC, Figureg WD: Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent. Biochem Pharmacol 55:1827-1834, 1998
-
(1998)
Biochem Pharmacol
, vol.55
, pp. 1827-1834
-
-
Bauer, K.S.1
Dixon, S.C.2
Figureg, W.D.3
-
27
-
-
20944437020
-
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma
-
Mattioli M, Agnelli L, Fabris S, et al: Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma. Oncogene 24:2461-2473, 2005
-
(2005)
Oncogene
, vol.24
, pp. 2461-2473
-
-
Mattioli, M.1
Agnelli, L.2
Fabris, S.3
-
28
-
-
0035942271
-
Significance analysis of microarrays applied to the ionizing radiation response
-
Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121, 2001
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 5116-5121
-
-
Tusher, V.G.1
Tibshirani, R.2
Chu, G.3
-
29
-
-
9144271651
-
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-Europe against cancer program
-
Beillard E, Pallisgaard N, van der Velden VH, et al: Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-Europe against cancer program Leukemia 17:2474-2486, 2003
-
(2003)
Leukemia
, vol.17
, pp. 2474-2486
-
-
Beillard, E.1
Pallisgaard, N.2
van der Velden, V.H.3
-
30
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
-
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408, 2001
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
31
-
-
10444265117
-
A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endotheiial cells of patients with multiple myeloma
-
Ria R, Vacca A, Russo F, et al: A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endotheiial cells of patients with multiple myeloma. Thromb Haemost 92:1438-1445, 2004
-
(2004)
Thromb Haemost
, vol.92
, pp. 1438-1445
-
-
Ria, R.1
Vacca, A.2
Russo, F.3
-
32
-
-
0031017221
-
Vascular endotheiial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma
-
Masood R, Cai J, Zheng T, et al: Vascular endotheiial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA 94:979-984, 1997
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 979-984
-
-
Masood, R.1
Cai, J.2
Zheng, T.3
-
33
-
-
9044228402
-
Basic fibroblast growth factor overexpression in endothelial cells: An autocrine mechanism for angiogenesis and angioproliferative diseases
-
Gualandris A, Rusnati M, Belleri M, et al: Basic fibroblast growth factor overexpression in endothelial cells: An autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth Differ 7:147-160, 1996
-
(1996)
Cell Growth Differ
, vol.7
, pp. 147-160
-
-
Gualandris, A.1
Rusnati, M.2
Belleri, M.3
-
34
-
-
3142767799
-
Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas
-
Streubel B, Chott A, Huber D, et al: Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med 351:250-259, 2004
-
(2004)
N Engl J Med
, vol.351
, pp. 250-259
-
-
Streubel, B.1
Chott, A.2
Huber, D.3
-
35
-
-
0030753430
-
Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression
-
Finkenzeller G, Sparacio A, Technau A, et al: Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15:669-676, 1997
-
(1997)
Oncogene
, vol.15
, pp. 669-676
-
-
Finkenzeller, G.1
Sparacio, A.2
Technau, A.3
-
36
-
-
2442466643
-
Transcriptional regulation of FGF-2 gene expression in cardiac myocytes
-
Jimenez SK, Sheikh F, Jin Y, et al: Transcriptional regulation of FGF-2 gene expression in cardiac myocytes. Cardiovasc Res 62:548-557, 2004
-
(2004)
Cardiovasc Res
, vol.62
, pp. 548-557
-
-
Jimenez, S.K.1
Sheikh, F.2
Jin, Y.3
-
37
-
-
0030793394
-
Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors
-
Jiang JG, Chen Q, Bell A, et al: Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors. Oncogene 14:3039-3049, 1997
-
(1997)
Oncogene
, vol.14
, pp. 3039-3049
-
-
Jiang, J.G.1
Chen, Q.2
Bell, A.3
-
38
-
-
0348011664
-
Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells
-
Li T, Chen YH, Liu TJ, et al: Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells. Circ Res 93:1202-1209, 2003
-
(2003)
Circ Res
, vol.93
, pp. 1202-1209
-
-
Li, T.1
Chen, Y.H.2
Liu, T.J.3
-
39
-
-
0036386341
-
Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: Alteration of the Sp1/Sp3/HDAC1 multiprotem complex
-
Choi HS, Lee JH, Park JG, et al: Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: Alteration of the Sp1/Sp3/HDAC1 multiprotem complex. Biochem Biophys Res Commun 296:1005-1012, 2002
-
(2002)
Biochem Biophys Res Commun
, vol.296
, pp. 1005-1012
-
-
Choi, H.S.1
Lee, J.H.2
Park, J.G.3
-
40
-
-
0034929708
-
Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer
-
Black AR, Black JD, Azizkhan-Clifford J: Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188:143-160, 2001
-
(2001)
J Cell Physiol
, vol.188
, pp. 143-160
-
-
Black, A.R.1
Black, J.D.2
Azizkhan-Clifford, J.3
-
42
-
-
0035137882
-
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kB
-
Baldwin AS: Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kB. J Clin Invest 107:241-246, 2001
-
(2001)
J Clin Invest
, vol.107
, pp. 241-246
-
-
Baldwin, A.S.1
-
43
-
-
0033876198
-
Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals
-
Sauer H, Gunther J, Heschler J, et al: Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals. Am J Pathol 156:151-158, 2000
-
(2000)
Am J Pathol
, vol.156
, pp. 151-158
-
-
Sauer, H.1
Gunther, J.2
Heschler, J.3
-
44
-
-
0347320849
-
A novel hypothesis for thalidomide-induced limb teratogenesis: Redox misregulation of the NF-kappaB pathway
-
Hansen JM, Harris C: A novel hypothesis for thalidomide-induced limb teratogenesis: Redox misregulation of the NF-kappaB pathway. Antioxid Redox Signal 6:1-14, 2004
-
(2004)
Antioxid Redox Signal
, vol.6
, pp. 1-14
-
-
Hansen, J.M.1
Harris, C.2
-
45
-
-
0030851721
-
Genomic organization of human and mouse genes for vascular endothelial growth factor C
-
Chilov D, Kukk E, Taira S, et al: Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem 272:25176-25183, 1997
-
(1997)
J Biol Chem
, vol.272
, pp. 25176-25183
-
-
Chilov, D.1
Kukk, E.2
Taira, S.3
-
46
-
-
0028029457
-
Functions of glutathione and glutathione disulfide in immunology and immunopathology
-
Droge W, Schulze-Osthoff K, Mihm S, et al: Functions of glutathione and glutathione disulfide in immunology and immunopathology FASEB J 8:1131-1138, 1994
-
(1994)
FASEB J
, vol.8
, pp. 1131-1138
-
-
Droge, W.1
Schulze-Osthoff, K.2
Mihm, S.3
-
47
-
-
0141449246
-
Treatment of relapsed and refractory multiple myeloma
-
Singhal S, Mehta J: Treatment of relapsed and refractory multiple myeloma. Curr Treat Options Oncol 4:229-237, 2003
-
(2003)
Curr Treat Options Oncol
, vol.4
, pp. 229-237
-
-
Singhal, S.1
Mehta, J.2
-
48
-
-
0347383743
-
Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent disease
-
Rajkumar SV: Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent disease. Semin Hematol 40:17-22, 2003
-
(2003)
Semin Hematol
, vol.40
, pp. 17-22
-
-
Rajkumar, S.V.1
|